- Home
- XPOF vs MIST Comparison
XPOF vs MIST Comparison
Compare XPOF & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPOF | MIST |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.2M | 176.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XPOF | MIST |
|---|---|---|
| Price | $7.21 | $2.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.13 | $8.00 |
| AVG Volume (30 Days) | 406.2K | ★ 3.3M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,092,000.00 | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | $6.91 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.83 | $0.88 |
| 52 Week High | $11.14 | $3.06 |
Technical Indicators
Market Signals| Indicator | XPOF | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 65.93 |
| Support Level | $6.81 | $1.84 |
| Resistance Level | $8.32 | $2.28 |
| Average True Range (ATR) | 0.42 | 0.19 |
| MACD | 0.08 | 0.08 |
| Stochastic Oscillator | 74.87 | 81.34 |
Price Performance
Historical ComparisonAbout XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).